About Celadon Partners
Celadon Partners is a private equity firm founded in 2018. It is primarily based in Taipei, Taiwan. In the last 12 months, it has participated in 1 funding round.
Overall Celadon Partners portfolio has seen 1 IPO, namely Senti Bio. A lot of funds co-invest with Celadon Partners, with names like Nantahala Capital Management sharing a substantial percentage of its portfolio.
Celadon Partners has a team of 11 people, including 2 partners.
Celadon Partners' Portfolio
They have invested in a total of 4 companies. Their most recent investment was in Senti Bio (Post IPO round) on May 02, 2026. Here is the most recent investment by Celadon Partners:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
May 02, 2026 | Post IPO | 7544 | - | |
Mar 18, 2025 | Seed | 1241 | ||
Dec 02, 2024 | Post IPO | 7867 | ||
May 07, 2024 | Series B | 3986 |
Here is the portfolio snapshot of Celadon Partners:
Investments by Year
The maximum number of investments were made in 2024
Team profile of Celadon Partners
Celadon Partners has a team of 11 members including 2 Partners and 3 Principals located in China, United States and 1 more location. Celadon Partners' team sits on the board of 1 company.Here is a list of top team members in Celadon Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | United States | |||
Partner | United States | - | ||
Principal | Hong Kong | - | ||
Principal | Hong Kong | - | - | |
Associate | Hong Kong | - | ||
Associate | China | - | ||
Associate | Hong Kong | - | ||
Analyst | Hong Kong | - | - | |
Analyst | China | - |
Co-investors of Celadon Partners
Over the past 8 years, 12 investors have co-invested in Celadon Partners's portfolio companies.
- Top Co-investors of Celadon Partners: 12 investors entered a company along with Celadon Partners. These include investors like Nantahala Capital Management (1 company).
Celadon Partners News
•
Senti Biosciences Secures Convertible Note Financing with CeladonTipRanks•May 16, 2026•Celadon Partners, Senti Bio
•
RegCell Raises $45.8M in FundingFinSMEs•Mar 18, 2025•RegCell, Utec, FTI, Celadon Partners and 3 others
•
Skender breaks ground on 105,000-square-foot supportive living facility in Deerfieldrejournals.com•Jan 23, 2025•Skender, Celadon Partners
•
Senti Biosciences receives additional investment of $10MSeeking Alpha•Jan 06, 2025•Senti Bio, Celadon Partners, New Enterprise Associates, Leaps by Bayer and 1 other
•
NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBioPR Newswire•May 08, 2024•Enterprise Singapore, NSG BioLabs, Merck, Celadon Partners and 2 others
•
NSG BioLabs partners with EnterpriseSG and Merck to boost biotech industrySingapore Business Review•May 07, 2024•NSG BioLabs, Merck, Enterprise Singapore, Celadon Partners and 1 other
•
NSG BioLabs bags USD 14.5 billion, SoftBank leads Wayve’s Series C round, 12 China and India deals, and moreKrASIA•May 07, 2024•NSG BioLabs, Celadon Partners, Clavystbio, Celadon Partners
•
GDMC secures $28.1m capital from Series A fundingSingapore Business Review•Jan 25, 2024•GDMC, Celadon Partners, WI Harper Group, SEEDS Capital and 2 others
•
Celadon Partners’ $38 Million Acquisition of Senti Bio’s AssetsGlobal Legal Chronicle•Sep 01, 2023•Senti Bio, Celadon Partners
•
Chicago-Area Supportive Living Facility Breaks GroundMulti-Housing News•Jun 25, 2021•Celadon Partners, Gleason Architects
